🔎 Trials Near Me

Home › Burkitt Lymphoma › Arizona

Burkitt Lymphoma clinical trials in Arizona

7 studies for Burkitt Lymphoma are looking for participants at sites in Arizona.

Cities in Arizona

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • Phoenix Childrens Hospital, Phoenix
  • Banner University Medical Center - Tucson, Tucson
RecruitingPhase 2
366 Days – 46 Years · All sexes · Updated Oct 2, 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Banner Children's at Desert, Mesa
RecruitingPhase 2
365 Days · All sexes · Updated Sep 25, 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Banner Children's at Desert, Mesa
  • Phoenix Childrens Hospital, Phoenix
  • Banner University Medical Center - Tucson, Tucson
RecruitingPhase 2
Ages 1 to 30 · All sexes · Updated Sep 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Banner Children's at Desert, Mesa
  • Phoenix Childrens Hospital, Phoenix
  • Banner University Medical Center - Tucson, Tucson
RecruitingPhase 3
365 Days – 25 Years · All sexes · Updated Aug 25, 2026 · NCT03959085

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • City of Hope at Phoenix, Phoenix
RecruitingPhase 2
Ages 18 to 54 · All sexes · Updated Mar 17, 2026 · NCT06918431

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Banner Health - MD Anderson Cancer Center, Gilbert
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05544019

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • Phoenix Children's Hospital, Phoenix
RecruitingPhase 2
Ages 1 to 25 · All sexes · Updated May 4, 2025 · NCT03509961

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.